HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Fritzen Selected Research

Highly Active Antiretroviral Therapy (HAART)

4/2006Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Fritzen Research Topics

Disease

1Primary Hyperparathyroidism
10/2007
1Parathyroid Neoplasms (Parathyroid Neoplasm)
10/2007
1Insulin Resistance
04/2006
1Lipodystrophy
04/2006
1HIV-Associated Lipodystrophy Syndrome
04/2006
1Graves Disease (Basedow Disease)
02/2004
1Hyperthyroidism
02/2004
1Neoplasms (Cancer)
11/2002
1Carcinoma (Carcinomatosis)
11/2002
1Neoplasm Metastasis (Metastasis)
11/2002

Drug/Important Bio-Agent (IBA)

1Parathyroid Hormone (Parathormone)IBA
10/2007
1Phosphates (Orthophosphate)IBA
10/2007
1CalciumIBA
10/2007
1Rosiglitazone (Avandia)FDA Link
04/2006
1CholesterolIBA
04/2006
1Triglycerides (Triacylglycerol)IBA
04/2006
1AutoantibodiesIBA
02/2004
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
02/2004
1Adrenocorticotropic Hormone (ACTH)FDA Link
11/2002

Therapy/Procedure

1Highly Active Antiretroviral Therapy (HAART)
04/2006